logo
#

Latest news with #JasonLi

Sewickley Academy graduate Jason Li advances to final qualifying for upcoming U.S. Open at Oakmont
Sewickley Academy graduate Jason Li advances to final qualifying for upcoming U.S. Open at Oakmont

CBS News

time05-05-2025

  • Sport
  • CBS News

Sewickley Academy graduate Jason Li advances to final qualifying for upcoming U.S. Open at Oakmont

Jason Li, a Sewickley Academy graduate, has advanced into final qualifying and will soon have a chance to try and earn a spot in the upcoming U.S. Open at Oakmont Country Club. Li, who won WPIAL and PIAA golf championships while at Sewickley Academy in high school, went on to play college golf at Carnegie Mellon and now has his eyes on qualifying for the U.S. Open that's being held in his hometown. Last week, Li fired a 67, shooting three under par in a qualifier match at the Country Club of York, earning co-medalist honors and advancing into final qualifying. Final qualifying will take place across the country as well as in Japan and in England on May 19 and on June 2. Should Li be able to qualify, he'll be teeing it up with the best in the world at Oakmont Country Club in mid-June when the U.S. Open returns to Oakmont for a record 10th time. Large crowds expected for 2025 U.S. Open When the USGA's biggest event rolls into Oakmont this summer, the man who's heading up this year's contest says the golfers will have a lot of eyes on them. "We're looking around 200,000 for the week," said Tim Lloyd, the USGA's senior director for the U.S. Open. The USGA is in the process of transforming the feared and revered course into a combination fair ground and golf proving ground, and they're on a tight schedule. The U.S. Open tournament will run from June 12 to June 15.

Jason Li, from martial arts to Hollywood stunt double and daredevil
Jason Li, from martial arts to Hollywood stunt double and daredevil

South China Morning Post

time01-04-2025

  • Entertainment
  • South China Morning Post

Jason Li, from martial arts to Hollywood stunt double and daredevil

The 1980s and 90s were the heyday for Hong Kong action movies , and I was exposed to a lot of that on television as a kid. My parents are from Hong Kong and I was born in 1990 in Texas, in the United States, where most of my mum's family live. My dad was a civil engineer and we moved to Hong Kong when I was three. I was a big fan of Power Rangers , a TV show that started off in Japan, about a bunch of people who have the ability to transform and enhance their powers to defend the Earth. My younger brother and I had Power Rangers toys and acted it out. Jet propulsion One of my favourite movies was The One (2001) , starring Jet Li . It was about parallel universes. There were a lot of really cool moments when he was fighting himself, which got me thinking about how they shot it. CGI wasn't advanced back then and they had to use stunt doubles and tricky camerawork. Jason Li (right) and his younger brother pictured in 1996. Photo: courtesy Jason Li The flip side I went to Chinese International School (CIS). I started doing martial arts when I was about nine and really got into it in my teens. I switched between doing wushu and taekwondo at CIS. Wushu takes a lot more discipline, which was one of the reasons I stopped for a bit, because I thought it was too restrictive. When YouTube came out, in 2005, I came across a video called Urban Ninja, which showed a guy doing random flips on the street. It moved my focus towards a sport called tricking – it's all the tricks of martial arts. Trials and errors One night my dad walked into my room and saw me watching a video of the tricks and said it looked dangerous and warned me not to do it. I understood he was looking out for me, but I still wanted to do it. After school, I trained with a couple of friends who were also into Chinese martial arts. I started with the front flip, running to get momentum. I like to describe it as if you are falling, but you fail to fall. And then you eat it over and over, hitting the deck. You have to start somewhere.

This week in PostMag: from André Fu's designs to stem cell therapy
This week in PostMag: from André Fu's designs to stem cell therapy

South China Morning Post

time29-03-2025

  • Entertainment
  • South China Morning Post

This week in PostMag: from André Fu's designs to stem cell therapy

Occasionally, there is one thing in the magazine that I just can't stop thinking about. This issue, it's the photo of Jason Li in My Life. Everything about that image is unexpected. How is he suspended in mid-air, completely horizontal and almost a metre from the ground? The pieces of a deconstructed taxi cab in the garage behind him just add to the improbability of the photograph. A great part of this job is these Easter eggs that land on my desk and leave me in awe – both of the subject and the people telling the story, whether photographers or writers. Check out the story and you'll see what I'm talking about. Advertisement At a party last weekend, a man told me his favourite part of PostMag every week is our long-running column My Life. It's one of my favourites, too. We're all a nosy bunch, aren't we? It's such a privilege when anyone, famous or not, opens up to tell us about how they got to where they are – the twists and turns of their journey, the entertaining anecdotes. I always find there's some existential relief in just hearing all the different ways a life can be lived. Li, a professional stunt double, tells Kate Whitehead about going from flips in a squash court to working on Transformers. In this week's main feature, Daven Wu looks at one of the most recent projects by The Upper House designer and architect André Fu. The new Dusit Thani Bangkok is Fu's 'confident mid-career masterwork', he writes, detailing how the architect strove to balance a desire for authenticity with the need for a contemporary feel and relevance. Fu's not slowing down either, ploughing ahead with a spate of openings across Shenzhen, Hong Kong, Taipei and Osaka. Elsewhere in Bangkok, Tim Noonan dives into the world of regenerative medicine as he recounts taking a chance (twice) on stem cell therapy. It's an approach I've never personally had to consider, thankfully, and it was enlightening to read a first-person account. Beyond Thailand, this issue travels around Asia with two features that share a commonality: fishermen and fishing nets. In Tokyo, Manami Okazaki joins the Sanja Matsuri, a festival that started as an homage to the fishermen who founded the city's oldest temple, Sensoji. It's a lively, raucous affair, complete with taiko drumming that often runs into the early hours. In Kerala, large cantilevered fishing nets led Vincent Chow down a rabbit hole as he explores both the historical and modern influence of the Chinese on India's southwestern state – a long, winding tale to spend some time with. Advertisement

Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research
Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research

Associated Press

time07-03-2025

  • Business
  • Associated Press

Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research

Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its website ( The advanced validation data, 3D Epitope Mapping, is designed to enhance the efficiency and accuracy of antibody-related selection, empowering scientists with the data they need to advance their work, from basic research to the design of novel therapeutics. This press release features multimedia. View the full release here: On the Proteintech website ( researchers can explore antibody binding sites with the new interactive 3D epitope viewer. (Photo: Business Wire) The 3D Epitope Mapping is a state-of-the-art solution that utilizes a combination of experimental techniques, including peptide scanning and microbial display, aiming to precisely map the antibody binding site (epitope) on a target protein. This mapping is then visualized in an interactive 3D view, which is based on published protein data and AI modelling. The 3D visualization provides scientists with a clear and detailed representation of the antibody-binding sites, enabling improved speed and precision of their antibody selection. In addition to the 3D Epitope Mapping, Proteintech improved the display of its immunogen information. The immunogen data is now displayed as a bar graph at the top of the search return pages, allowing users to select antibodies based on their immunogen of interest. 'We are thrilled to be the first antibody supplier to offer advanced product information that we believe will make a significant impact on the life science community. As the original manufacturer of these products, we believe we are uniquely positioned to be able to provide this data to scientists. We plan to have our entire catalog mapped in the near future,' said Dr. Jason Li, CEO at Proteintech. 'With more epitopes mapped, we hope the days when scientists have to try multiple antibodies for one experiment are behind us. Scientists deserve better when they are fighting for the future of mankind.' Proteintech Group Inc., founded in 2001, is a leading manufacturer of antibodies, proteins, nanobodies, and immunoassays. Proteintech has the largest proprietary portfolio of self-manufactured antibodies covering two-thirds of the human proteome. Proteintech offers antibodies, proteins and immunoassays across research areas with over 300,000 products cited. In addition, Proteintech produces cytokines, growth factors and other proteins that are human expressed, bioactive and cGMP-grade. Proteintech sites are ISO13485 and ISO9001 accredited. ph: 312-455-8498 INDUSTRY KEYWORD: MEDICAL SUPPLIES BIOTECHNOLOGY MANAGED CARE HEALTH PHARMACEUTICAL HEALTH TECHNOLOGY OTHER SCIENCE RESEARCH HOSPITALS GENETICS SCIENCE SOURCE: Proteintech Group Inc. Copyright Business Wire 2025. PUB: 03/07/2025 02:16 PM/DISC: 03/07/2025 02:17 PM

Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research
Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research

Yahoo

time07-03-2025

  • Business
  • Yahoo

Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research

ROSEMONT, Ill., March 07, 2025--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its website ( The advanced validation data, 3D Epitope Mapping, is designed to enhance the efficiency and accuracy of antibody-related selection, empowering scientists with the data they need to advance their work, from basic research to the design of novel therapeutics. The 3D Epitope Mapping is a state-of-the-art solution that utilizes a combination of experimental techniques, including peptide scanning and microbial display, aiming to precisely map the antibody binding site (epitope) on a target protein. This mapping is then visualized in an interactive 3D view, which is based on published protein data and AI modelling. The 3D visualization provides scientists with a clear and detailed representation of the antibody-binding sites, enabling improved speed and precision of their antibody selection. In addition to the 3D Epitope Mapping, Proteintech improved the display of its immunogen information. The immunogen data is now displayed as a bar graph at the top of the search return pages, allowing users to select antibodies based on their immunogen of interest. "We are thrilled to be the first antibody supplier to offer advanced product information that we believe will make a significant impact on the life science community. As the original manufacturer of these products, we believe we are uniquely positioned to be able to provide this data to scientists. We plan to have our entire catalog mapped in the near future," said Dr. Jason Li, CEO at Proteintech. "With more epitopes mapped, we hope the days when scientists have to try multiple antibodies for one experiment are behind us. Scientists deserve better when they are fighting for the future of mankind." About Proteintech Proteintech Group Inc., founded in 2001, is a leading manufacturer of antibodies, proteins, nanobodies, and immunoassays. Proteintech has the largest proprietary portfolio of self-manufactured antibodies covering two-thirds of the human proteome. Proteintech offers antibodies, proteins and immunoassays across research areas with over 300,000 products cited. In addition, Proteintech produces cytokines, growth factors and other proteins that are human expressed, bioactive and cGMP-grade. Proteintech sites are ISO13485 and ISO9001 accredited. For more information, visit View source version on Contacts Katie Bellowskatie@ ph: 312-455-8498 Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store